Materials and methods for protecting against neuromas

Patent metadata

Field	Value
Publication number	US-10945805-B2
Application number	US-202016786042-A
Country	US
Kind code	B2
Filing date	Feb 10, 2020
Priority date	Sep 25, 2012
Publication date	Mar 16, 2021
Grant date	Mar 16, 2021

Abstract

The subject invention provides devices and methods for alleviating discomfort associated with neuroma formation. The devices and methods of the invention effectively use the body's natural response of reconstructing implanted biomaterials to minimize the size of isolate, and protect a neuroma. In preferred embodiments, the subject device is a cylindrical cap, wherein the internal chamber of the cylindrical cap physically partitions the nerve to enable an arrangement of nerve fibers (as opposed to haphazardly arranged nerve fibers often produced in neuromas). Tabs arranged on the outside of the cap can be used to manipulate the cap into place on a nerve. The open end can also be configured with flaps that can be used to widen the open end for easier insertion of the nerve into the cap. In addition, the cap's material remodels into a tissue cushion after implantation, which protects the neuroma from being stimulated and inducing pain.

First claim

We claim:

1. A device comprising:
a body having an open proximal end and a closed distal end integrally formed with the body, wherein the body, including the closed distal end, defines an internal chamber, without openings other than at the proximal end, wherein the internal chamber is physically partitioned; and
a biomaterial that remodels into a tissue cushion after implantation;
wherein the body of the device is between about 1 mm and about 100 mm in length.

2. The device according to claim 1 , wherein the device comprises a biomaterial selected from the group consisting of high density polyethylene (HDPE), polyethylene glycol (PEG) hydrogel, and purified protein from human or other sources.

3. The device according to claim 1 , wherein the device comprises a biomaterial selected from the group consisting of small intestine submucosa (SIS), amnion, dermis, collagen, and decellularized fascia.

4. The device according to claim 1 , wherein the body is cylindrical in shape.

5. A method of using the device according to claim 1 , comprising inserting a nerve stump into the proximal end of the device.

6. The method of claim 5 . wherein a neuroma formed out of the inserted nerve stump is protected from external stimuli.

7. A method for preventing or limiting neuroma formation comprising inserting and securing a nerve stump into a device according to claim 1 .

8. The method of claim 7 , wherein neuroma formation is limited as compared to neuroma formation in the absence of said device.

9. A method comprising:
inserting and securing a nerve stump into a device according to claim 1 ; and
decreasing the pain associated with a neuroma formation as compared to the pain associated with a neuroma formation in the absence of said device.

Assignees

• Axogen Corp

Inventors

• Deister Curt
• Simon Crystal
• Faleris Jennifer

Classifications

• A61L31/04 Primary

  Macromolecular materials · CPC title

• A61L27/3675

  Nerve tissue, e.g. brain, spinal cord, nerves, dura mater · CPC title

• A61L31/06

  obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} · CPC title

• A61L31/048

  obtained by reactions only involving carbon-to-carbon unsaturated bonds (A61L31/041 takes precedence) · CPC title

• A61L31/005

  Ingredients of undetermined constitution or reaction products thereof · CPC title